Men's Health Clinical Trials
Here are the 6 most popular medical studies in Men's Health Clinical Trials
Opioid Antagonist
Naltrexone + Ecological Momentary Intervention for Methamphetamine Addiction
Recruiting0 awardsPhase 2
San Francisco, California
This trial will test the effectiveness of naltrexone, an as-needed medication, in reducing meth use among 54 MSM who use meth. The trial will last 12 weeks and will compare naltrexone to placebo.
Alkylating agents
Chemotherapy + Rucaparib for Prostate Cancer
Recruiting1 awardPhase 2
Seattle, Washington
This trial studies how well a combination of docetaxel, carboplatin, and rucaparib camsylate works in treating patients with metastatic prostate cancer that is resistant to testosterone suppression and has defects in the ability to repair mistakes in DNA.
Popular filter options for Men's Health Clinical Trials trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
18F-DCFPyL PET/CT Imaging for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Montreal, Quebec
This trial is testing a new way to image prostate cancer in order to better understand how to treat it. Patients will receive an injection and then have a PET/CT scan. A panel of experts will review the images to see if they can better understand how to manage the disease.
Monoclonal Antibodies
Concizumab for Hemophilia
Recruiting2 awardsPhase 3
Orange, California
This trial will test how well a new medicine, concizumab, works in the bodies of people with haemophilia A or B with inhibitors. The purpose is to show that concizumab can prevent bleeds in the body and is safe to use.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Gonadotropin-Releasing Hormone (GnRH) Antagonist
Relugolix +1 More for Prostate Adenocarcinoma
Recruiting1 awardPhase 2
Columbus, Ohio
This trial compares the effects of two different treatments, relugolix and leuprolide, on heart health and performance in prostate cancer patients. Androgen deprivation therapy (ADT) is commonly
Imaging Agent
PSMA-PET/CT Guided Biopsy for Prostate Cancer
Recruiting1 awardPhase < 1
Los Angeles, California
This trial is testing a new way to do a prostate biopsy, using a PSMA protein found on prostate cancer cells. The new biopsy is done with a PET/CT scan and may help improve the detection rate of prostate cancer.
18F-DCFPyL PET/CT Imaging for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Montreal, Quebec
This trial is testing a new way to image prostate cancer in order to better understand how to treat it. Patients will receive an injection and then have a PET/CT scan. A panel of experts will review the images to see if they can better understand how to manage the disease.
View More Men's Health Clinical Trials Trials
See another 80 medical studies focused on Men's Health Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.